245 HAMMERSMITH ROAD, 3RD FLOOR, LONDON, X0
News, Reorganization Plan
Other Events
Material disclosure
Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH
Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
Announces Presentation of Additional Positive Data from Proof-of-concept Study of OTL-203 in MPS-IH at ESGCT 2023
Q3
Q2
Q1
FY 2022
FY 2021
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Merger Proxy Statement
Definitive Additional Proxy Soliciting Materials
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
S-8 POS
Post-Effective Amendment to Registration Statement